Current Portfolio
FoRx Therapeutics
oRx Therapeutics focuses on drugging key molecular targets involved in the DNA Replication Stress as a new approach in the developments.
Key Facts
- Sector
Life Sciences
- Country
Switzerland
- Fund
LSP 6
- Entry
2019
Website
Do You Want to Know More?
We are eager to explore how we can achieve great things together.